Combined Analysis of CSF Tau, Aβ42, Aβ1–42% and Aβ1–40(ox)% in Alzheimer's Disease, Dementia with Lewy Bodies and Parkinson's Disease Dementia

類似資料

• CSF amyloid-β-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia
  著者:: Bibl, Mirko, 等
  出版事項: (2006)
• Selective reduction of amyloid β42 discriminates Alzheimer's disease from Huntington's disease: indication for distinct pathological events in amyloid β peptide aggregation
  著者:: Mollenhauer, B, 等
  出版事項: (2006)
• Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia
  著者:: Bibl, Mirko, 等
  出版事項: (2012)
• Correction to: Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia
  著者:: Bibl, Mirko, 等
  出版事項: (2018)
• Plasma Amyloid‐BetaPeptides in Acute Cerebral Ischemia: A Pilot Study
  著者:: Bibl, Mirko, 等
  出版事項: (2012)